4//SEC Filing
SHERMAN JEFFREY W 4
Accession 0001867096-23-000154
CIK 0001867096other
Filed
Nov 28, 7:00 PM ET
Accepted
Nov 29, 4:09 PM ET
Size
5.5 KB
Accession
0001867096-23-000154
Insider Transaction Report
Form 4
SHERMAN JEFFREY W
Director
Transactions
- Purchase
Common Stock
2023-11-27$1.87/sh+5,400$10,098→ 5,400 total(indirect: By Trust)
Holdings
- 107,878
Common Stock
Footnotes (1)
- [F1]The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
Documents
Issuer
Xeris Biopharma Holdings, Inc.
CIK 0001867096
Entity typeother
Related Parties
1- filerCIK 0001230482
Filing Metadata
- Form type
- 4
- Filed
- Nov 28, 7:00 PM ET
- Accepted
- Nov 29, 4:09 PM ET
- Size
- 5.5 KB